Patents by Inventor Maximilian Muenke

Maximilian Muenke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS
    Publication number: 20130012497
    Abstract: The invention provides methods of determining an altered susceptibility to develop ADHD, methods of predicting or determining the severity of symptoms of ADHD and associated disorders, and methods of treatment based on the presence or absence of one or more alleles of single nucleotide polymorphism (SNP) markers.
    Type: Application
    Filed: May 18, 2012
    Publication date: January 10, 2013
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Ser.
    Inventors: Maximilian Muenke, Mauricio Arcos-Burgos, Maria Teresa Acosta
  • Methods for detecting attention-deficit/hyperactivity disorder
    Patent number: 8003406
    Abstract: The invention provides a method of determining a susceptibility of a subject for development of ADHD. The method comprises obtaining a sample from the subject, analyzing the sample for an ADHD susceptibility haplotype of LPHN3 receptor which is associated with at least one genetic marker selected from the group consisting of rs7678046, rs1901223, rs6813183, and rs1355368, and determining if the subject has a susceptibility to develop ADHD, whereby the presence of the haplotype having one or more of the genetic markers is indicative of a susceptibility to develop ADHD. The invention also provides methods of treating ADHD.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: August 23, 2011
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Maximilian Muenke, Mauricio Arcos-Burgos, F. Xavier Castellanos
  • METHODS FOR DETECTING AND TREATING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Publication number: 20100040626
    Abstract: The invention provides a method of determining a susceptibility of a subject for development of ADHD. The method comprises obtaining a sample from the subject, analyzing the sample for an ADHD susceptibility haplotype of LPHN3 receptor which is associated with at least one genetic marker selected from the group consisting of rs7678046, rs1901223, rs6813183, and rs1355368, and determining if the subject has a susceptibility to develop ADHD, whereby the presence of the haplotype having one or more of the genetic markers is indicative of a susceptibility to develop ADHD. The invention also provides methods of treating ADHD.
    Type: Application
    Filed: September 27, 2007
    Publication date: February 18, 2010
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Maximilian Muenke, Mauricio Arcos-Burgos, F. Xavier Castellanos